A longitudinal study of serum insulin and glucose levels in relation to colorectal cancer risk among postmenopausal women

British Journal of Cancer

Volumn 106, Issue 1, 2012, Pages 227-232

  Kabat, G C ^a   Kim, M Y ^a   Strickler, H D ^a   Shikany, J M ^b   Lane, D ^c   Luo, J ^d   Ning, Y ^e   Gunter, M J ^f   Rohan, T E ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b University of Alabama at Birmingham   (United States)

^c STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^d WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

colorectal cancer; glucose; homeostasis model assessment insulin resistance; serum insulin

Indexed keywords

GLUCOSE; INSULIN;

ADULT; AGED; ARTICLE; CANCER RISK; COLORECTAL CANCER; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LONGITUDINAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY;

AGED; BLOOD GLUCOSE; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INSULIN; LONGITUDINAL STUDIES; MIDDLE AGED; POSTMENOPAUSE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES;

EID: 84855339767     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.512     Document Type: Article

References (39)

1. Bergmeyer HU (ed.) (1974) Methods of Enzymatic Analysis. 2nd Engl ed., p 1196. Academic Press: New York
2. Bjork J, Nilsson J, Hultcrantz R, Johansson C (1993) Growth-regulatory effects of sensory neuropeptides, epidermal growth factor, insulin, and somatostatin on the non-transformed intestinal epithelial cell line IEC-6 and the colon cancer cell line HT 29. Scand J Gastroenterol 28(10): 879-884 (Pubitemid 23294761)
3. Bruce WR, Corpet DE (1996) The colonic protein fermentation and insulin resistance hypotheses for colon cancer etiology: experimental tests using precursor lesions. Eur J Cancer Prev 5(Suppl 2): 41-47 (Pubitemid 27085338)
4. Chlebowski RT, Chen Z, Anderson GL, Rohan T, Aragaki A, Lane D, Dolan NC, Paskett ED, McTiernan A, Hubbell FA, Adams-Campbell LL, Prentice R (2005) Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst 97(6): 439-448
5. Curb JD, McTiernan A, Heckbert SR, Kooperberg C, Stanford J, Nevitt M, Johnson KC, Proulx-Burns L, Pastore L, Criqui M, Daugherty S (2003) Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Ann Epidemiol 13(5): S122-S128 (Pubitemid 37324181)
6. Flood A, Mai V, Pfeiffer R, Kahle L, Remaley AT, Lanza E, Schatzkin A (2007) Elevated serum concentrations of insulin and glucose increase risk of recurrent colorectal adenomas. Gastroenterology 133(5): 1423-1429 (Pubitemid 350029750)
7. Gail MH (1981) Evaluating serial cancer marker studies in patients at risk of recurrent disease. Biometrics 37(1): 67-78
8. Giovannucci E (1995) Insulin and colon cancer. Cancer Causes Control 6(2): 164-179
9. Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Rohan TE, Manson JE, Howard BV, Wylie-Rosett J, Anderson GL, Ho GY, Kaplan RC, Li J, Xue X, Harris TG, Burk RD, Strickler HD (2008) Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women. Cancer Res 68(1): 329-337 (Pubitemid 351380136)
10. Howard BV, Adams-Campbell L, Allen C, Black H, Passaro M, Rodabough RJ, Rodriguez BL, Safford M, Stevens VJ, Wagenknecht LE (2004) Insulin resistance and weight gain in postmenopausal women of diverse ethnic groups. Int J Obes Relat Metab Disord 28(8): 1039-1047 (Pubitemid 38998711)
11. Huxley RR, Ansary-Moghaddam A, Clifton P, Czernichow S, Parr CL, Woodward M (2009) The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. Int J Cancer 125(1): 171-180
12. Ikeda Y, Suehiro T, Nakamura T, Kumon Y, Hashimoto K (2001) Clinical significance of the insulin resistance index as assessed by homeostasis model assessment. Endocr J 48(1): 81-86 (Pubitemid 32230388)
13. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM (2005) Fasting serum glucose level and cancer risk in Korean men and women. JAMA 293(2): 194-202 (Pubitemid 40095870)
14. Jenab M, Riboli E, Cleveland RJ, Norat T, Rinaldi S, Nieters A, Biessy C, Tjonneland A, Olsen A, Overvad K, Gronbaek H, Clavel-Chapelon F, Boutron-Ruault MC, Linseisen J, Boeing H, Pischon T, Trichopoulos D, Oikonomou E, Trichopoulou A, Panico S, Vineis P, Berrino F, Tumino R, Masala G, Peters PH, Van Gils CH, Bueno-de-Mesquita HB, Ocke MC, Lund E, Mendez MA, Tormo MJ, Barricarte A, Martinez-Garcia C, Dorronsoro M, Quiros JR, Hallmans G, Palmqvist R, Berglund G, Manjer J, Key T, Allen NE, Bingham S, Khaw KT, Cust A, Kaaks R (2007) Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 121(2): 368-376 (Pubitemid 46917707)
15. Kaaks R, Toniolo P, Akhmedkhanov A, Lukanova A, Biessy C, Dechaud H, Rinaldi S, Zeleniuch-Jacquotte A, Shore RE, Riboli E (2000) Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst 92(19): 1592-1600
16. Koenuma M, Yamori T, Tsuruo T (1989) Insulin and insulin-like growth factor 1 stimulate proliferation of metastatic variants of colon carcinoma 26. Jpn J Cancer Res 80(1): 51-58 (Pubitemid 20027198)
17. Limburg PJ, Stolzenberg-Solomon RZ, Vierkant RA, Roberts K, Sellers TA, Taylor PR, Virtamo J, Cerhan JR, Albanes D (2006) Insulin, glucose, insulin resistance, and incident colorectal cancer in male smokers. Clin Gastroenterol Hepatol 4(12): 1514-1521 (Pubitemid 44880028)
18. Ma J, Giovannucci E, Pollak M, Leavitt A, Tao Y, Gaziano JM, Stampfer MJ (2004) A prospective study of plasma C-peptide and colorectal cancer risk in men. J Natl Cancer Inst 96(7): 546-553 (Pubitemid 38559579)
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7): 412-419 (Pubitemid 15018832)
20. McKeown-Eyssen G (1994) Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomarkers Prev 3(8): 687-695 (Pubitemid 24377963)
21. Moghaddam AA, Woodward M, Huxley R (2007) Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70000 events. Cancer Epidemiol Biomarkers Prev 16(12): 2533-2547 (Pubitemid 351196307)
22. Nilsen TI, Vatten LJ (2001) Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis. Br J Cancer 84(3): 417-422 (Pubitemid 32154439)
23. Ning Y, Wang L, Giovannucci EL (2010) A quantitative analysis of body mass index and colorectal cancer: findings from 56 observational studies. Obes Rev 11(1): 19-30
24. Otani T, Iwasaki M, Sasazuki S, Inoue M, Tsugane S (2007) Plasma C-peptide, insulin-like growth factor-I, insulin-like growth factor binding proteins and risk of colorectal cancer in a nested case-control study: the Japan public health center-based prospective study. Int J Cancer 120(9): 2007-2012 (Pubitemid 46418381)
25. Palmqvist R, Stattin P, Rinaldi S, Biessy C, Stenling R, Riboli E, Hallmans G, Kaaks R (2003) Plasma insulin, IGF-binding proteins-1 and-2 and risk of colorectal cancer: a prospective study in northern Sweden. Int J Cancer 107(1): 89-93 (Pubitemid 37100090)
26. Peterson JI, Young DS (1968) Evaluation of the hexokinase-glucose-6- phosphate dehydrogenase method of determination of glucose in urine. Anal Biochem 23(2): 301-316
27. Saydah SH, Platz EA, Rifai N, Pollak MN, Brancati FL, Helzlsouer KJ (2003) Association of markers of insulin and glucose control with subsequent colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 12(5): 412-418 (Pubitemid 36578478)
28. Schoen RE, Tangen CM, Kuller LH, Burke GL, Cushman M, Tracy RP, Dobs A, Savage PJ (1999) Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst 91(13): 1147-1154 (Pubitemid 29330553)
29. Stocks T, Lukanova A, Bjorge T, Ulmer H, Manjer J, Almquist M, Concin H, Engeland A, Hallmans G, Nagel G, Tretli S, Veierod MB, Jonsson H, Stattin P (2011) Metabolic factors and the risk of colorectal cancer in 580 000 men and women in the metabolic syndrome and cancer project (Me-Can). Cancer 117: 2398-2407
30. Strickler HD, Wylie-Rosett J, Rohan T, Hoover DR, Smoller S, Burk RD, Yu H (2001) The relation of type 2 diabetes and cancer. Diabetes Technol Ther 3(2): 263-274 (Pubitemid 32651962)
31. The Women's Health Initiative Study Group (1998) Design of the Women's Health Initiative clinical trial and observational study. Control Clin Trials 19(1): 61-109
32. Tietz NW. (ed) (1987) Fundamentals of Clinical Chemistry 3rd ed., p 544. WB Saunders Co: Philadelphia, PA
33. Trevisan M, Liu J, Muti P, Misciagna G, Menotti A, Fucci F (2001) Markers of insulin resistance and colorectal cancer mortality. Cancer Epidemiol Biomarkers Prev 10(9): 937-941 (Pubitemid 32844900)
34. Tsushima M, Nomura AM, Lee J, Stemmermann GN (2005) Prospective study of the association of serum triglyceride and glucose with colorectal cancer. Dig Dis Sci 50(3): 499-505 (Pubitemid 40543738)
35. Warburg O (1956) On the origin of cancer cells. Science 123(3191): 309-314
36. Wei EK, Ma J, Pollak MN, Rifai N, Fuchs CS, Hankinson SE, Giovannucci E (2005) A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 14(4): 850-855 (Pubitemid 40478547)
37. Werner H, LeRoith D (1996) The role of the insulin-like growth factor system in human cancer. Adv Cancer Res 68: 183-223
38. Wu X, Fan Z, Masui H, Rosen N, Mendelsohn J (1995) Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin. J Clin Invest 95(4): 1897-1905
39. Yamada K, Araki S, Tamura M, Sakai I, Takahashi Y, Kashihara H, Kono S (1998) Relation of serum total cholesterol, serum triglycerides and fasting plasma glucose to colorectal carcinoma in situ. Int J Epidemiol 27(5): 794-798 (Pubitemid 28504966)